Fluoroquinolones for the Treatment of Pulmonary Tuberculosis
Authors:
- 1 January 2007
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 67 (14) , 2077-2099
Abstract
Tuberculosis (TB) continues to be a significant problem globally. Treatment includes a multiple drug regimen with isoniazid, rifampicin (rifampin), pyrazinamide and ethambutol. Often, one of these...Keywords
This publication has 43 references indexed in Scilit:
- Fluoroquinolones for treating tuberculosis2005
- Uncontrolled trial of sparfloxacin in retreatment of pulmonary tuberculosisRespirology, 2004
- Mycobacterium tuberculosis DNA Gyrase: Interaction with Quinolones and Correlation with Antimycobacterial Drug ActivityAntimicrobial Agents and Chemotherapy, 2004
- CDC Sexually Transmitted Diseases Treatment GuidelinesClinical Infectious Diseases, 2002
- Practice Guidelines for the Management of Infectious DiarrheaClinical Infectious Diseases, 2001
- Evaluation of an Intensive Intermittent‐Induction Regimen and Duration of Short‐Course Treatment for Human Immunodeficiency Virus–Related Pulmonary TuberculosisClinical Infectious Diseases, 1998
- Randomized Controlled Trial of a Drug Regimen That Includes Ciproftoxacin for the Treatment of Pulmonary TuberculosisClinical Infectious Diseases, 1996
- Treatment of Multidrug-Resistant Tuberculosis in TaiwanChemotherapy, 1996
- Safety profile of ciprofloxacin during long-term therapy for pulmonary tuberculosisJournal of Antimicrobial Chemotherapy, 1993
- In-vitro activity of ofloxacin against Mycobacterium tuberculosis and its clinical efficacy in multiply resistant pulmonary tuberculosisJournal of Antimicrobial Chemotherapy, 1990